STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB)

CUSIP: 34385P108

Q4 2016 13F Holders as of 31 Dec 2016

Holder snapshot 7 signals
Share change
-1,021,262
Put/Call ratio
178%
SEC-reported price per share
$7.28
Number of holders
80
Value change
-$9,634,235
Number of buys
31
Open additional details 1 more signal available
Number of sells
48
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
391,007,800

Security key

34385P108

Report period

Q4 2016

Institutions

80

Top holders

10

Ownership snapshot

Top reported holders of LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
LEVIN CAPITAL STRATEGIES,...
Disclosed value leader
LEVIN CAPITAL STRATEGIES,...
Comparable rows
15/15
Latest evidence
30 Sep 2016
13F Lead comparable stake: 1.1% Showing 1-6 of 15 holder rows.

Quick read

LEVIN CAPITAL STRATEGIES, L.P. leads the comparable SEC ownership view at 1.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens LEVIN CAPITAL STRATEGIES, L.P.'s linked filing trail.
Comparable ownership Top 5
LEVIN CAPITAL STRATEGIES, L.P. 1.1%
PRIMECAP MANAGEMENT CO/CA/ 1.1%
FRANKLIN RESOURCES INC 0.51%
WASATCH ADVISORS LP 0.48%
ORBIMED ADVISORS LLC 0.45%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
LEVIN CAPITAL STRATEGIES, L.P.
13F
Company
13F
1.1%
$35,126,000
4,385,263 shares
30 Sep 2016
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
1.1%
$34,165,000
4,265,332 shares
30 Sep 2016
FRANKLIN RESOURCES INC
13F
Company
13F
0.51%
$15,931,000
1,988,962 shares
30 Sep 2016
WASATCH ADVISORS LP
13F
Company
13F
0.48%
$15,019,000
1,874,997 shares
30 Sep 2016
ORBIMED ADVISORS LLC
13F
Company
13F
0.45%
$13,986,000
1,746,100 shares
30 Sep 2016
Emerald Acquisition Ltd.
13F
Company
13F
0.43%
$13,606,000
1,698,654 shares
30 Sep 2016
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2016

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
80
Shares
26,899,693
Rows available
80
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders
91
Q4 2016 holders
80
Holder diff
-11
Investor Q3 2016 Shares Q4 2016 Shares Share Diff Share Chg % Q3 2016 value Q4 2016 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .